Semenax, manufactured by Leading Edge Health, is a supplement specifically designed to increase semen volume and intensify ...

NICE today announced that it has been named a Leader in the 2025 Aragon Research GlobeTM for AI Agent Platforms in the Intelligent Contact Center report. The Globe identified NICE for its strengths, ...

New York, New York-- (Newsfile Corp. - April 17, 2025) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Viatris Inc. (NASDAQ: VTRS) between August 8, 2024 ...

Arkansas has enacted a law making it the first state banning pharmacy benefit managers from owning a pharmacy in the state.

CSSi LifeSciences, a global regulatory consulting firm specializing in guiding drug and medical device companies through FDA approvals, is excited to announce its official rebrand to QNova ...

DelveInsight's "TRYVIO/JERAYGO Market Size, Forecast, and Market Insight Report" highlights the details around TRYVIO/JERAYGO ...

The US Senate Judiciary Committee advanced to the full Senate six bills intended to reduce pharmaceutical prices and enhance ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic and Mounjaro, the pharmaceutical company says.

Now that he's stepped away from "Shark Tank" and sold his majority stake in the Mavericks, Mark Cuban has a new goal in mind: ...

The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, reaching US$354.6 million in 2025 and an impressive US$560.5 million ...

The global Immune Repertoire Sequencing Market, valued at US$344.2 million in 2024, is forecasted to grow at a robust CAGR of 9.6%, ...

TRYVIO (aprocitentan) in the US and JERAYGO in Europe present significant market potential as novel therapies for patients with hypertension inadequately controlled by existing treatments. TRYVIO ...